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Available online 27 May 2016Background:Dengue virus (DENV) is amosquito-borne ﬂavivirus that causes signiﬁcant human disease andmor-
tality in the tropics and subtropics. By examining the effects of virus infection on gene expression, and interac-
tions between virus and vector, new targets for prevention of infection and novel treatments may be identiﬁed
in mosquitoes. We previously performed a microarray analysis of the Aedes aegypti transcriptome during infec-
tion with DENV and found that mosquito ubiquitin protein Ub3881 (AAEL003881) was speciﬁcally and highly
down-regulated. Ubiquitin proteins have multiple functions in insects, including marking proteins for
proteasomal degradation, regulating apoptosis and mediating innate immune signaling.
Methods:We used qRT-PCR to quantify gene expression and infection, and RNAi to reduce Ub3881 expression.
Mosquitoeswere infectedwithDENV throughblood feeding.We transfectedDENVprotein expression constructs
to examine the effect of Ub3881 on protein degradation. We used site-directed mutagenesis and transfection to
determine what amino acids are involved in Ub3881-mediated protein degradation. Immunoﬂuorescence, Co-
immunoprecipitation and Western blotting were used to examine protein interactions and co-localization.
Results: The overexpression of Ub3881, but not related ubiquitin proteins, decreased DENV infection inmosquito
cells and live Ae. aegypti. The Ub3881 protein was demonstrated to be involved in DENV envelope protein deg-
radation and reduce the number of infectious virions released.
Conclusions: We conclude that Ub3881 has several antiviral functions in the mosquito, including speciﬁc viral
protein degradation.
General signiﬁcance:Our data highlights Ub3881 as a target for future DENVprevention strategies in themosquito
transmission vector.







Dengue virus (DENV) is a globally signiﬁcant mosquito-borne ﬂavi-
virus responsible for serious disease and mortality. There are over
2.5 billion people at risk of DENV infectionworldwide,with 50–100mil-
lion new cases each year andwithmore than 100 endemic countries [1].
There is no speciﬁc treatment for DENV infection and efforts to create a
vaccine have been hindered by safety issues and antibody-dependentolpitts).
. This is an open access article underenhancement (ADE) [2,3]. There are four serotypes of DENV, and infec-
tion with one does not provide protection against secondary infection
with another serotype. This can potentially lead to immunopathology
due to ADE, often resulting in severe forms of denguediseases, including
dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS)
[2–7].
Aedes aegypti is the main mosquito vector responsible for transmit-
ting DENV to humans. This mosquito is well-adapted to live in areas of
human habitation as it regularly enters residences to feed and prefers
humans to other vertebrates. Once a mosquito acquires virus from an
infected person, DENV needs 7–10 days to replicate in the vector before
the mosquito can transmit virus to a new host [8,9]. In many dengue-the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ture of Ae. aegypti and the tendency for many family members to
share one house. The standard control measures to prevent the spread
of DENV in endemic areas rely on use of insecticides, larval habitat re-
duction [10], and surveillance, but the incidence of dengue fever (DF)
and DHF continues to rise each year. Other, innovative means for vector
management and disease prevention are necessary for complete control
of this disease [6,11–13].
As traditional avenues for prevention and treatment may not prove
completely effective against DENV, there exists an opportunity for ex-
ploring novel methods of stopping DENV spread by careful evaluation
of viral pathogenesis and interaction with the mosquito vector. The
targeting, modiﬁcation or elimination of speciﬁc genes in Ae. aegypti
could reduce vector competence for virus acquisition [8,14,15]. A
study by our laboratory identiﬁed a number of mosquito genes that
had signiﬁcantly altered expression during ﬂavivirus infection [16].
One of these genes that encodes a ubiquitin (Ub) protein (SeqID
AAEL003881) was signiﬁcantly down-regulated at all time-points ex-
amined in Ae. aegypti during infection with DENV. Investigation of the
impact of Ub3881 on DENV infection in the mosquito as well as the
mechanisms responsible for the down-regulation of Ub3881 during in-
fection will help determine whether the protein can be used to inhibit
DENV in the transmission vector.
Ubiquitin is a globular protein that is extremely conserved in all eu-
karyote cells with a highly homologous protein sequence in all animals
from insects to humans. It is comprised of 76 amino acids and usually
contains seven conserved lysine (K) residues: K6, K11, K27, K29, K33,
K48, and K63 [17]. Ubiquitin has many varying functions, including
marking regulatory proteins for degradation, regulating apoptosis, acti-
vating the immune system, cell proliferation, cell differentiation, and
cell survival [18–20]. Each ubiquitin lysine attachment creates varied
structures and determines the outcome of the target protein [17,21].
The process of ubiquitination is quite complex with many pathways
and functions in virtually every cell type.
Though ubiquitination is an important protein modiﬁcation for nor-
mal cell cycle functions, it is also required for andmanipulated bymany
viruses, including ﬂaviviruses [22–24]. For example, several
coronaviruses cannot exit the endosome with an impaired ubiquitin-
proteasome system [25] and proteasomal inhibitors are known to
block the endocytosis of inﬂuenza virus [26]. The ubiquitin ligase
CBLL1 has been shown to be crucial for the internalization of West
Nile virus (WNV) in mammalian cells [27]. Both herpes simplex virus
type 1 (HSV-1) and human papillomavirus (HPV) are able to direct
the tumor suppressor protein p53 for proteasomal degradation through
manipulation of ubiquitin ligases [28], and human immunodeﬁciency
virus (HIV) proteins recruit the formation of the host E3 ubiquitin ligase
complex to induce degradation of both APOBEC-3G and CD4 [29,30]. In-
hibition of the ubiquitin-proteasome system has also been shown to
block various steps in the replication of several viruses, including poxvi-
ruses, coxsackie virus 3B, respiratory syncytial virus and WNV [31–35].
Research in primary human endothelial cells revealed a requirement for
a ubiquitin-activating enzyme E1 and a proteasome subunit during
DENV infection, demonstrating the important role that ubiquitination
plays during the DENV life cycle [36]. There was also a recent report
that DENV infection in mosquitoes may be dependent on a functioning
ubiquitin proteasome system [37]. However, a comprehensive picture
of the role of ubiquitin and individual ubiquitin pathway proteins dur-
ing DENV infection in the mosquito transmission vector is still lacking.
Here, we examine the impact of varying levels of Ub3881 on DENV
infection inmosquito cells and liveAe. aegypti, and examine the require-
ments for theubiquitin-protease systemduringDENV infection of insect
cells in vitro.We also explore variousmechanisms likely involved in the
antiviral action of Ub3881 during DENV infection. Our data sheds light
on the role that Ub3881 plays during DENV infection in the mosquito
vector and highlights a possible target protein for controlling DENV
transmission.2. Methods
2.1. Cell culture and virus growth
The Aag2 Ae. aegypti cell line was used for transfection and infection
studies. The cells were grown at 30 °C and 5% CO2 in DMEM supple-
mented with 10% heat-inactivated fetal bovine serum (Gemini, CA),
1% penicillin-streptomycin and 1% tryptose phosphate broth (Sigma,
MO). Dengue virus stock was grown in C6/36 Aedes albopictus cell line
using the same media. The dengue strain used was DENV-2 New
Guinea C. Cells were infected at an m.o.i. of 1.0, virus was allowed to
propagate for 6–8 days, supernatant was removed, spun down and
virus stock was stored at−80 °C until use.
2.2. Mosquito infections
The Rockefeller strain of Ae. aegyptiwere infected by blood-feeding,
using 400 μL of DENV-infected C6/36 cell supernatant (10^4 pfu) added
to 1 mL serum-inactivated human blood (purchased from The Blood
Center, New Orleans, LA). Blood was tested in our laboratory and was
negative for the presence of ﬂavivirus or ﬂaviviral antibodies. Mosqui-
toes were fed for 20 min at room temperature using a hemotek feeder
and maintained in groups of 10 at 30 °C, 80% humidity. Mosquitoes
were supplied sucrose water as a source of dietary sugar. At the conclu-
sion of experiments, mosquitoes were brieﬂy washed in 70% ethanol
and then rinsed in sterile PBS. Organs were dissected in sterile PBS
and transferred to Eppendorf tubes separately. Mosquito organs were
stored in PBS with protease inhibitors for protein assays and homoge-
nized in RLT buffer (Qiagen, CA) for gene expression assays.
2.3. qRT-PCR analysis
RNAwas isolated from infected Ae. aegyptimosquitoes on Days 1, 2,
7 and puriﬁed using RNeasy kit (Qiagen, CA) according to
manufacturer's instructions. The quantitative RT-PCR analysis was
done using the QuantiFast kit according to manufacturer's instructions
(Qiagen, CA). Oligos for the qRT-PCR reactions were:
DENV envelope: F: 5′-CATTCCAAGTGAGAATCTCTTTGTCA-3′, R: 5′-
CAGATCTCTGATGAATAACCAACG-3′; Ae. aegypti Actin: F: 5′-GAACAC
CCAGTCCTGCTGACA-3′, R: 5′-TGCGTCATCTTCTCACGGTTAG-3′; Ae.
aegypti Ub3881: F: 5′-CCGGTCTGGCCGAGGACGAAACC-3′, R: 5′-CAGG
CCTGGCCACCTCTC-3′.
2.4. Mosquito injections
DNAplasmidswere injected according to our publishedwhole-body
transfection method [38]. Brieﬂy, Cellfectin II (Invitrogen, CA) was
mixed with S2 Schneider's medium at a 1:1 ratio and then keep at RT
for 10min. PlasmidDNAwas combinedwith thismixture and incubated
at RT for 30 min before thoracic microinjection into Aedes aegypti. Mos-
quitoes were injected with 500 ng plasmid/300 nL solution. The siRNA
was dissolved in sterile PBS and injected into the thorax in a similar
manner at varying concentrations for optimization.
siRNA molecules used were: Ub3881: 5′-aagaagauggucgaagcccgg-
3′; GAPDH: proprietary sequence, Ambion catalog # AM4605.
2.5. Immunoﬂuorescence analysis
Aag2 Ae. aegypti cells were infected with DENV at an MOI of 0.1. At
24 h post-infection, infected cells and control cells were ﬁxed in 4%
paraformaldehyde for 20 min at RT, washed with PBS(−) and then
stained for infection using antibodies against Ub3881, Imdor Relish pro-
teins (made at Yale Keck Center), DENV envelope gene (Millipore, MA)
and/or 19S proteasome (Abcam,MA). The antibodieswere diluted in 1%
BSA at 1/250 and cells were incubated for 20 min at RT. All secondary
antibodies used were standard (anti-mouse or anti-rabbit TRITC and
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tion was visualized using ﬂuorescent microscopy, equipment and spe-
ciﬁcs can be found in ﬁgure legends.
2.6. Western blots
Solutions were run on a 4–12% SDS-PAGE gel for 1.5 h at 15 mA per
gel (unless ﬁgure legend indicates otherwise). The proteins were then
transferred to PVDF membrane. The membrane was blocked with 5%
milk in 1% TBST for 1 h at RT and then incubated with the appropriate
primary antibody overnight at 4 °C. The membrane was washed and
then incubated with the appropriate horseradish peroxidase secondary
antibody for 1 h at RT. The protein blots were incubated with ECL sub-
strates (Amersham, NJ) for 5min at RT and then detected on Kodak ﬁlm.
2.7. Transfection of plasmids
The expression plasmids were made from pAc5.1/V5-His A vector
(Invitrogen, CA) and cloning was done using PCR along with gene-
speciﬁc primers as previously described [39]. We used the Qiagen
mini-prep kit to isolate DNA from bacterial cultures after transforming
DH5-alpha cells. Plasmids were transfected into cells using Effectene
(Qiagen, CA) according to manufacturer's instructions. Brieﬂy, for a
10 cm2 plate, 10 μg of DNA was mixed with 500 μL buffer EC and 32 μL
enhancer was added. This was allowed to incubate for 5 min on the
benchtop. Then, 30 μL Effectene reagent was added and the solution
vortexed brieﬂy. After 10 min incubation, the solution was added to
the cells. Expression was observed 24 h post-transfection and peaked
at 48 h.
2.8. Protein interactions
Antibodies against Ub3881 (Supplementary Table 3) were bound to
protein A/G beads and used to probe Ae. aegypti lysate. The bound
Ub3881 was eluted and interacting partners in solution were analyzed
by LC/MS-MS. All steps were done at 4 °C to maintain the protein inter-
actions. The eluted proteins were analyzed at the Yale University W.M.
Keck Foundation core facility. The eluatewas subjected to trypsin diges-
tion followed by LC/MS-MS (liquid chromatography and mass
spectometry) for peptide sequencing and identiﬁcation using the re-
cently completed Aedes aegyptimosquito genome [40]. Putative mos-
quito proteins were identiﬁed via amino acid sequence identity to
both known mosquito proteins and their mammalian counterparts
using the BLAST software on the NCBI website. A portion of the solution
was also run on an SDS-PAGE gel and Western blot analysis was done
with the Ub3881 antibody. In addition, antibodies against Ub3881 and
mosquito Imd proteins were used to precipitate proteins out of DENV-
infected mosquito lysate. The solutions were run on an SDS-PAGE gel
andWestern blot analysis was done using the antibody against Ub3881.
3. Results
3.1. Ub3881 is speciﬁcally down-regulated by DENV infection
We previously identiﬁed mosquito genes that had differential ex-
pression during infection with West Nile virus (WNV), yellow fever
virus (YFV) and dengue virus (DENV). Many genes were highly down-
regulated during infection with all three viruses, including an ubiquitin
protein thatwe have designated Ub3881 (AAEL003881) (Table S1) [16].
The Ub3881 genewas the onlymosquito ubiquitin in our screen to have
signiﬁcantly altered expression during DENV infection (Fig. 1A and
Table S2). An alignment of mosquito ubiquitin genes analyzed is
shown in Fig. 1B (with the exception of AAEL008920, as the active
length is not complete in the published Ae. aegypti genome). Interest-
ingly, the Ub3881 protein has several variations in amino acid sequence
when compared to the canonical universal ubiquitin protein sequence(Fig. 1B), including an asparagine (N) in place of the lysine at position
63 (K63) and an alanine inserted at position 19. To conﬁrm that
Ub3881 expression is lower during DENV infection of the mosquito,
we repeated the infection and analysis. Total RNA was isolated from
mosquitoes on 1, 2 and 7 days post-infection (dpi) and qRT-PCR analysis
done to quantify levels of mosquito ubiquitin gene expression.We con-
ﬁrmed that Ub3881 is signiﬁcantly down-regulated during DENV infec-
tion of Ae. aegypti at all time-points analyzed and that other ubiquitin
genes did not have signiﬁcantly altered gene expression (Fig. 1C). We
also used lysate from homogenizedmosquitoes to conﬁrmUb3881 pro-
tein reduction during DENV infection at the same timepoints (Fig. S1).
3.2. Ub3881 gene expression and regulation during infection is tissue-
speciﬁc
During infection of the mosquito, DENV must ﬁrst infect the midgut
(MG), and then disseminate through the body to the salivary glands
(SG), which is critical for transmission to a new host. To determine
the tissue-speciﬁc expression of Ub3881 during infection, we orally in-
fected Ae. aegypti with DENV and dissected MG and SG on 1, 2 and
7 dpi. We performed qRT-PCR analysis on RNA isolated at each time
point to determine levels of gene expression (Fig. 1D). On day 1 of
DENV infection, Ub3881 was over 8-fold down-regulated in the SG of
the mosquitoes. The decrease in Ub3881 expression in the MG was
around 2-fold on day 1 (Fig. 1D). On day 2 of infection, the expression
of Ub3881 was over 4-fold down-regulated in both the SG and MG
(Fig. 1D). On day 7, the expression in the SG was over 6-fold lower in
the DENV- infected mosquitoes and expression in MG had around a 5-
fold decrease (Fig. 1D). These results suggest a complex balance of
Ub3881 gene regulation throughout themosquito and in the individual
organs duringDENV infection. This also indicates that, as in humans, the
infectious process can lead to systemic pathological changes very early
in DENV infection, perhaps through signaling pathways and/or mole-
cules traveling in mosquito hemolymph.
3.3. Overexpression of Ub3881 inhibits DENV infection inmosquito cells and
live mosquitoes
Wehypothesize that DENV infectionmay speciﬁcally down-regulate
Ub3881 expression in the mosquito to combat antiviral effects on the
DENV life cycle. To investigate whether Ub3881 has anti-DENV proper-
ties, we chose to overexpress theUb3881 gene and analyze the resulting
DENV infection. The coding regions for Ub3881, and the representative
ubiquitin gene Ub6511 whose expression was not altered by DENV in-
fection in themosquito (Fig. 1C), were cloned into the insect expression
vector pAc5.1/V5-His (Life Technologies, CA). The expression vectors
were transfected into an Ae. aegypti mosquito cell line, Aag2, and the
cells were infected with DENV. The overexpression of either protein
had no signiﬁcant cytotoxic effect on the cells. We found that the over-
expression of Ub3881 caused a 6-fold reduction in DENV infection as
compared to control infectionwith GFP transfection (Fig. 2A), and over-
expression of Ub6551 did not signiﬁcantly alter infection levels. Next,
we analyzed the effects of Ub3881 overexpression on DENV infection
in mosquitoes. We injected Ae. aegypti with the expression vectors
using awhole-body transfectionmethod thatwe usedwith success pre-
viously [38]. We ﬁrst analyzed gene expression in the mosquitoes at 3
and 14 days post-microinjection (dpmi) to conﬁrm that expression of
Ub3881 was increased after plasmid transfection. We found that ex-
pression of Ub3881 was increased by an average of 1000-fold at 3 and
14 dpmi in the injectedmosquitoes (Fig. 2B).We then injectedmosqui-
toes with the Ub3881 expression vector and infected them with DENV
via blood feeding at 5 dpmi. Mosquito MG and SG were dissected on
8 dpi, total RNAwas isolated and qRT-PCR analysis was done to quantify
DENV infection levels. As shown in Fig. 2C, DENV infection was down
10- to 25-fold in the mosquito MG and reduced up to 10-fold in the
mosquito SG during Ub3881 overexpression. These data demonstrate
Fig. 1. Ubiquitin protein Ub3881 expression is decreased during DENV infection in Ae. aegypti. A. Ae. .aegyptiwere infected with DENV and microarray analysis for gene expression was
done at 1, 2 and 7 days post-infection on isolated RNA, known ubiquitin family genes are shown. P b 0.05. Pooled mosquitoes. Experimental and technical replicates were done in
triplicate. B. Alignment using ClustalOmega of the ﬁrst active length of the ubiquitin genes from 1A. C/D. Mosquitoes were infected with DENV via blood feeding and at 1, 2 and 7 days
post-infection, C. RNA was isolated from whole mosquitoes or D. RNA was isolated from dissected midguts and salivary glands. qRT-PCR analysis was done to measure expression of
ubiquitin genes. Experimental and technical replicates were done in triplicate. P b 0.05. Statistical analysis done using ANOVA and Students t-tests. Fold-change in expression is shown
as compared to uninfected, bloodfed mosquitoes.
1901A. Troupin et al. / Biochimica et Biophysica Acta 1860 (2016) 1898–1909that increased Ub3881 reduces DENV infection in Ae. aegypti and that
the reduction occurs in bothMG and SG, the organs involved in acquisi-
tion and transmission of virus.
3.4. DENV infection efﬁciently regulates expression of Ub3881
Since DENV infection reduced Ub3881 expression in the mosquito,
and increasing Ub3881 reduced DENV infection, we hypothesized that
further reduction of Ub3881may increase levels of infection. To investi-
gate this, we used RNA interference (RNAi) to block the expression of
Ub3881 with siRNA molecules designed against the Ub3881 gene. Thestandard insect RNAi method of injecting dsRNA transcribed from the
target gene could not be performed due to the potential of non-
speciﬁc knock-down. Therefore, an siRNA molecule against a gene-
speciﬁc coding region of Ub3881 was used so that the inhibition of ex-
pression would be speciﬁc. We transfected the Ub3881 siRNA into
Aag2 cells and infected the cells with DENV 72 h post-transfection
(hpt). This timepoint was chosen after carefully examining Ub3881
knockdown at 24–168 hpt. The Ub3881 was over 80% reduced at
72 hpt and expression remained down until the 168 timepoint. At 24,
36, 48, 72 and 96 h post-infection (hpi), cellular RNA was analyzed by
qRT-PCR for infection levels. Reduction in Ub3881 resulted in a slight
Fig. 2. The overexpression of Ub3881 inhibits DENV infection in Ae. aegypti. A. Aag2mosquito cells were transfectedwith expression plasmids encoding either Ub3881 or a representative
ubiquitinUb6551 and cellswere infectedwithDENV. qRT-PCR analysiswas done tomeasure DENV infection. P b 0.001. B.Ae. aegyptimosquitoeswere transfectedwith Ub3881 expression
plasmid and qRT-PCR analysis was done to measure Ub3881 expression at D3 and D14. C. Mosquitoes overexpressing Ub3881 were infected with DENV via blood feeding at D5 post-
transfection. At D8 post-infection, midgut and salivary glands were dissected and analyzed by qRT-PCR to measure DENV infection. P b 0.001. D. Aag2 cells were transfected with
either mosquito Ub3881 siRNA or human GAPDH siRNA (control) and infected with DENV 72 h post-transfection. Cells were analyzed by qRT-PCR at various timepoints to measure
DENV infection. E. Mosquitoes were injected with siRNA targeting either Ub3881 or human GAPDH and infected with DENV by blood feeding 7 days post-injection. At day 5 post-
infection, qRT-PCR analysis was done to measure DENV infection.
1902 A. Troupin et al. / Biochimica et Biophysica Acta 1860 (2016) 1898–1909increase in DENV infection in the cells (Fig. 2D) but it was not signiﬁ-
cant. Next, we used the siRNA in live Ae. aegypti to reduce the Ub3881
levels prior to DENV infection. The siRNA was intrathoracically injected
according to our previousmethods [16,41] andmosquitoes were infect-
ed with DENV by blood feeding at 7 dpmi. At 5 dpi, RNA was isolated
from mosquitoes for qRT-PCR analysis. We found a slight increase in
DENV infection in the mosquitoes with reduced Ub3881 (Fig. 2E) but
the difference was not statistically signiﬁcant. This indicated both that
Ub3881 may not be inhibitory to initial virus entry and that the
Ub3881 down-regulation caused by DENV infection is sufﬁcient for suc-
cessful infection.
3.5. Ub3881 reduces the number or infectivity of dengue virions produced
Since we found that Ub3881may have antiviral activity, we hypoth-
esized that the overexpression of Ub3881 would negatively impact in-
fectious DENV production. To examine this, we transfected the
Ub3881 expression plasmid into Aag2 cells and then infected with
DENV 24 h post-transfection. A different set of cells was transfected
with a GFP plasmid as a control. Since we wanted to investigate the
number and quality of virions produced from the cells with andwithout
Ub3881 overexpression, we assayed the infectivity cell supernatants.
First, we used the supernatant in a plaque assay on uninfected Vero
cells. We found that the supernatant from Aag2 cells that were overex-
pressing Ub3881 resulted in a lower number of plaques than the super-
natant from the control cells (Fig. 3A). This indicated that there is less
infectious virus in cells that are overexpressing Ub3881. We next used
the supernatant to infect a new set of cells, both Aag2 mosquito and
Huh7 human liver cells. We found that, again, the supernatant from
cells that were overexpressing Ub3881 resulted in lower infection, as
measured by qRT-PCR (Fig. 3B/C). We also measured the DENV in thesupernatant from the original transfected/infected Aag2 cells to quanti-
fy DENV. We determined that there was less DENV in the supernatant
from cells that had Ub3881 transfected than the supernatant from con-
trol cells (Fig. 3D). Finally, we performed qRT-PCR analysis to quantify
DENV infection over time in the original Aag2 cells, with and without
Ub3881 overexpression. We found that DENV infection rapidly in-
creases over time in the control cells and the cells that had Ub3881
transfected showed signiﬁcantly lower DENV infection, especially at
later timepoints (Fig. 3E). Together, this data suggest that Ub3881 ex-
pression results in less infectious dengue virions produced in the cells.
3.6. Ub3881 expression impacts immune signaling in DENV-infected mos-
quito cells
One function of ubiquitin in insects is to regulate immune signaling
[42,43]. Thus, the suppression of DENV infection by Ub3881 might be
due to the activated state of antiviral immune pathways. Ubiquitin can
regulate Imd immune signaling via attachment to the Imd protein,
which may result in the transcription of innate immune genes, such as
antimicrobial peptides (AMPs) [44]. In addition, the Imd pathway was
recently shown to be involved in antiviral immunity in insects [45,46].
Thus, quantiﬁcation of AMP expression levels was analyzed during
Ub3881 overexpression and DENV infection. Aag2 cells were
transfected with Ub3881 or Ub6551 expression vectors and infected
with DENV 24 hpt. Levels of AMP genes were analyzed by qRT-PCR at
48 hpi. We found that several AMP genes, including cecropin, attacin,
defensin and diptericin, had signiﬁcantly increased levels during DENV
infection with the addition of Ub3881 overexpression, as compared to
cells overexpressing Ub6551 or DENV infection alone (Fig. 4A,
Table S4).We hypothesized that the Ub3881-induced expression of im-
mune genes may be signaled through the Imd pathway. Therefore, we
Fig. 3.Ub3881 reduces production of infectious DENV. Aag2 cells were transfectedwith expression plasmids encoding either Ub3881 or GFP, and 24 h post-transfection cells were infected
with DENV. A–D. Cell culture supernatants were collected 48 h post-infection. A. Supernatants were used in a plaque assay on Vero cells to quantify infectious DENV. Plaque forming units
per mL (PFU/mL) are shown on log scale. B/C. Supernatants were used to infect Aag2 (B) and Huh7 (C) cells and cell lysates were used in qRT-PCR analysis to quantify DENV infection. D.
Supernatants were used in qRT-PCR analysis to quantify virions produced in original infection. E. Original Aag2 cell lysateswere used in qRT-PCR to quantify DENV virus growth over time.
Lysates were collected at 48 h post-infection. All graphs shown in this ﬁgure have P b 0.01 and statistical P-values were calculated using students t tests.
1903A. Troupin et al. / Biochimica et Biophysica Acta 1860 (2016) 1898–1909next sought to determine if the Ub3881 directly interacted with the
Aedes Imd protein. To investigate this, we used antibody against the
Ae. aegypti Imd coding sequence that we had produced (Table S3,
Fig. S2) in an immunoprecipitation assay (IP) to pull down Ub3881
binding partners from whole Ae. aegypti lysates. The precipitated solu-
tion was sent for LC/MS-MS analysis to determine which proteins
interacted with mosquito Ub3881. A Western blot of the eluate is
shown in Fig. 4B and a list of the proteins identiﬁed in the elution solu-
tion is shown in Table 1. We identiﬁed both Aedes Imd protein and sev-
eral 26S proteasome proteins as putative Ub3881 interactors. Several
vitellogenin proteins were also identiﬁed as Ub3881 binding partners.
To conﬁrm that there was an interaction between Ub3881 and mosqui-
to Imd protein, we used the antibodies we had made against each pro-
tein to precipitate them from DENV-infected Ae. aegypti lysates. We ran
the precipitated solutions on SDS-PAGE gels and used Western blot
analysis with the antibody against Ub3881. The results shown in Fig.
4C demonstrate that Ub3881 protein was pulled out with both the
Ub3881 antibody and the antibody against mosquito Imd protein.
Next, we used the antibodies to localize both Ub3881 and Imd in Aag2
cell lines during DENV infection (Fig. 4D). These results indicate that
there is an interaction betweenUb3881 and Imd in themosquito during
DENV infection, and this interaction could be driving increased produc-
tion of AMPs.
Another function of ubiquitin in insects is the initiation of cellular
apoptosis, for example, through the ubiquitination of the inhibitor of ap-
optosis (IAP) protein [47,48]. To investigate whether Ub3881 may initi-
ate apoptosis in mosquito cells during DENV infection, we transfected
Aag2 cells with Ub3881 and/or infected cells with DENV. We thenperformed immunoﬂuorescence analysis on cells that had overexpres-
sion of Ub3881 and measured apoptosis using an antibody recognizing
cleaved caspase-3 protein. The cleavage of caspase-3 is commonly
used as an indicator of cellular apoptosis and the antibody against
human caspase-3 recognizes the cleaved (active) protein in insect
cells [49,50]. We found that the cells with increased Ub3881 expression
had increased levels of cleaved caspase-3 as compared to the cells with
no Ub3881 overexpression (Fig. 4E), indicating increased apoptosis. Fig.
4E presents 3 mosquito cells, as indicated by DAPI blue ﬂuorescence.
Only the single green cell, indicating overexpression of Ub3881, also
had red ﬂuorescence, which indicated increased cleaved caspase-3.
We then didWestern blot analysis on the cell lysates using the same an-
tibody against cleaved caspase-3. We again found that the addition of
Ub3881 alonewas sufﬁcient to induce apoptosis, as indicated by the in-
crease in cleaved caspase-3 (Fig. 4F). Infection with DENV without the
overexpression of Ub3881 resulted in a slight induction in apoptosis
but not nearly as substantial as with the increased Ub3881 protein
(Fig. 4F). The transfection of Ub3881 along with the infection with
DENV caused the greatest increase in cleaved caspase-3 protein
(Fig. 4F, far right panel). We then looked at how a loss of Ub3881 func-
tion might affect apoptosis during DENV infection by using RNAi to
block Ub3881 expression in Aag2 cells. Cells were infected with DENV
andWestern blot analysis done to check for cleaved caspase-3. Infection
with DENV again increased apoptosis as compared to uninfected cells.
Interestingly, a reduction in Ub3881 expression lowered the DENV-
stimulated increase in apoptosis, providing further evidence that
Ub3881 might be involved in apoptosis during DENV infection in mos-
quito cells (Fig. S3).
Fig. 4.Ub3881 is involved inmosquito antiviral pathways. A. Aag2 cells were transfectedwith expression plasmids encoding either Ub6511 or Ub3881 and infectedwith DENV 24 h post-
transfection. At 48 h post-infection, cells were analyzed by qRT-PCR for expression of select antimicrobial peptides (AMPs). B. Antibodies against Ub3881were bound to protein A/G beads
and used to probe Ae. aegypti lysate. The bound Ub3881 (and partners) was eluted and interacting partners in solutionwere analyzed by LC/MS-MS (see Table 1). A portion of the solution
was also run on an SDS-PAGE gel and Western blot analysis was done with the Ub3881 antibody. C. Antibodies produced against Ub3881 and mosquito Imd proteins were used to
precipitate proteins out of DENV-infected mosquito lysate. The solutions were run on an SDS-PAGE gel and Western blot analysis was done using the antibody against Ub3881. D.
Aag2 cells were infected with DENV and immunoﬂuorescence analysis was done using antibodies against Ub3881 and mosquito Imd protein to localize the proteins in the cells. A
representative image is shown; images were taken at 20×. E. Aag2 cells were transfected with Ub3881 and immunoﬂuorescence analysis was done using antibodies against Ub3881
and cleaved caspase-3 to demonstrate increased apoptosis with increased Ub3881 expression. Green cells have overexpression of Ub3881 and red cells have labeled Representative
cells are shown; images were taken at 20×. F. Aag2 cells were transfected with Ub3881 or a mock expression plasmid and infected with DENV 24 h post-transfection. A group of
control cells were not infected. Cell lysates were run on SDS-PAGE gels and Western blot analysis was done with antibodies against cleaved caspase-3 as a marker for apoptosis.
Mock = uninfected, mock transfected; Ub3881 = uninfected, Ub3881-transfected; DENV = DENV-infected, mock transfected; and DENV-Ub3881 = DENV-infected, Ub3881-
transfected. All Western blots were run with corresponding amounts of protein per lane as loading controls.
Table 1
Ub3881 binding partners in Ae. aegypti.
Protein ID Name Score Expectation
gi|108873755 Imd 679 2.3E-61
gi|472308 Vitellogenin-A 586 4.1E-52
gi|37528873 Vitellogenin-B 1005 4.9E-94
gi|37528871 Vitellogenin-C 606 4.1E-54
gi|157110191 Ub-enzyme E1 1097 3.3E-103
gi|157127055 26S proteasome subunit 7 172 1E-10
gi|157124938 26S proteasome non-ATPase subunit 151 1.3E-8
gi|1709799 26S proteasome subunit 8 514 7.4E-45
gi|157132413 26S proteasome subunit S9 489 2E-42
gi|157106603 26S proteasome subunit S10b 482 1.5E-41
gi|157125334 Importin beta-3 1009 2E-94
gi|157126954 Importin beta-4 572 1E-50
gi|157108446 Coatamer (COPA) 462 1.1E-39
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inhibition
A known function of ubiquitin is to bind proteins and target them for
proteasomal degradation [51]. To this end,we sought to reduce the anti-
DENV effects of Ub3881 in mosquito cells by chemically inhibiting the
proteasome system. The Ub3881 gene was overexpressed in Aag2
cells and the cells were treated with the proteasome inhibitor
carbobenzoxy-L-leucyl-L-leucyl-L-leucinal (MG132) prior to DENV in-
fection. Control cells were transfectedwith GFP plasmid. Infection levels
were analyzed using isolated RNA and qRT-PCR analysis. MG132 has
successfully been used to inhibit the proteasome in insect cells previ-
ously [52] and we found no cellular toxicity in our assays at the levels
used. Surprisingly, blocking proteasomal activity did not reduce the an-
tiviral effects of Ub3881 (Fig. 5A), though blocking activity also reduced
DENV infection in cells without Ub3881 overexpression (Fig. 5A). We
next looked at the effects of Ub3881 overexpression with proteasomal
inhibition over time and found no signiﬁcant changes within the ﬁrst
96 h of infection (Fig. 5B). It is important to note that previous research
Fig. 5. Proteasomal inhibition does not block antiviral effects of Ub3881. A. Aag2 cells were transfectedwith Ub3881 expression vector or control GFP vector and then treatedwithMG132
proteasome inhibitor prior to and throughout DENV infection. Infection was measured by qRT-PCR analysis. B. Aag2 cells were treated with MG132 proteasome inhibitor and then
transfected with the Ub3881 expression vector or control GFP vector prior to DENV infection. MG132 treatment was continued throughout infection. RNA was isolated from the cells
over time and DENV infection was measured by qRT-PCR analysis. C. Aag2 cells were transfected with the Ub3881 expression vector or a control GFP vector and then treated with
MG132 proteasome inhibitor prior to and throughout DENV infection. Cell supernatants were used in qRT-PCR analysis to quantify DENV release from cells. D. Aag2 cells were infected
with DENV and immunoﬂuorescence analysis was done using antibodies against the 19S proteasome and Ub3881. Mock (uninfected) cells were used as controls. Representative
images are shown; images were taken at 63×.
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replication [35], thus the reduction of proteasomal activitymay have di-
rectly caused the inhibition of DENV infection seenhere. To conﬁrm that
virus release also remained reduced with overexpression of Ub3881
during proteasomal inhibition, we alsomeasured DENV in the superna-
tant by qRT-PCR. We found that MG132 did not stop Ub3881 from
inhibiting DENV virus production in the cells (Fig. 5C). We next exam-
ined whether Ub3881 interacts with the 26S proteasome to determine
if this ubiquitin is involved in the mosquito proteasome pathway. We
looked at the association between the proteasome and Ub3881 in
Aag2 cells with andwithout DENV infection using polyclonal antibodies
that we had made against Ub3881 and antibodies recognizing the 19S
regulatory complex of the proteasome. Cells were then examined by
ﬂuorescence microscopy and co-localization of Ub3881 and the protea-
some was seen both with and without DENV infection (Fig. 5D). This
suggested that Ub3881 may be involved in the mosquito ubiquitin-
proteasome pathway and could be marking proteins for degradation.
3.8. Ub3881 targets the DENV envelope protein for degradation
We next hypothesized that Ub3881 may be attaching to DENV pro-
teins and labeling them for destruction, thereby inhibiting the viral life
cycle. To investigate this, we overexpressed Ub3881 in Aag2 cells, in-
fected the cells with DENV and performed Western blot analysis on
cell lysates to detect levels of individual DENV proteins. The cells ex-
pressing Ub3881 had much lower levels of all viral proteins than the
control cells (Fig. 6A), which suggested that the Ub3881 protein was in-
deed degrading viral proteins. However, since the overexpression of
Ub3881 impairs viral infection, it is possible that the protein levels
were lower due to a reduction in viral RNA rather than via proteindegradation. To address this, we expressed Ub3881 in Aag2 cells and
then separately transfected plasmids expressing each of the individual
DENV proteins. We performed Western blot analysis on the cell lysates
to measure viral protein levels. This time, the levels of most DENV pro-
teins did not changewith increasedUb3881 expression,with the excep-
tion of the envelope (E) protein (Fig. 6B). This indicated that the Ub3881
may be speciﬁcally targeting E for degradation, which could be one of
the main antiviral mechanisms. This also supports that levels of other
viral proteins were low due to the reduced viral RNA levels rather
than proteasomal degradation. Looking at the sequence of DENV E, we
found that there are 3 putative ubiquitination sites within the sequence
at lysines K88, K157 and K163 (Fig. S4), which indicates that the
ubiquitination of DENV E by Ub3881 is likely. To determine whether
these putative ubiquitination sites are involved, we made DENV E mu-
tant genes individually replacing the lysines with alanines, resulting in
DENV E K88A, K157A and K163A. We cloned these gene mutants into
the insect expression vector and transfected these, with and without
the Ub3881 expression vector, into Aag2 cells. We performed Western
blot analysis on the cell lysates to determine the levels of E protein.
Each of the lysate samples from cells overexpressing mutant E protein,
lacking one of the three putative ubiquitination sites, had greater
amounts of E protein than the cells expressing wild-type DENV E
along with Ub3881 (Fig. 6C), with the K157A mutant retaining the
most DENV E relative to the cells expressing wild-type E. This indicated
that all three of the putative ubiquitination sites are likely involved in
the Ub3881-DENV E interaction and resulting degradation of DENV E,
and that the lysine at position 157 is the most likely to be involved. To
conﬁrm that Ub3881 interacts with DENV E, we ran eluate pulled
from infected Ae. aegypti lysate using the Ub3881 antibody on an SDS-
PAGE gel and did Western blotting analysis using an antibody against
Fig. 6.DENV envelope protein is speciﬁcally degraded by Ub3881. A. Aag2 cells were transfectedwith the Ub3881 expression vector or a mock expression vector and infectedwith DENV.
The cell lysate was run on an SDS-PAGE gel and Western blot analysis was done with antibodies against each individual DENV protein. B. Aag2 cells were individually transfected with
expression plasmids encoding for each DENV protein, along with the Ub3881 expression plasmid or a mock expression plasmid. Equal amounts of protein from the cell lysates were
run on SDS-PAGE gels and Western blot analysis was done with antibodies against each individual DENV protein. C. Aag2 cells were individually transfected with expression plasmids
expressing DENV envelope protein, along with the Ub3881 expression plasmid or a mock expression plasmid. The envelope protein coding regions were WT, K88A, K157A or K163A.
Cell lysates were run on SDS-PAGE gels and Western blot analysis was done with antibodies against DENV envelope protein. D. Antibodies against Ub3881 and DENV E proteins were
used to precipitate proteins out of DENV-infected mosquito lysate. The solutions were run on an SDS-PAGE gel and Western blot analysis was done using the antibody against DENV E
protein. E. Aag2 cells were transfected with the Ub3881 expression plasmid and infected with DENV 24 h post-transfection. Cells were analyzed by immunoﬂuorescence microscopy
using antibodies against DENV E and Ub3881. A representative image is shown; images were taken at 40×. Western blots were run with corresponding amounts of protein per lane as
loading control.
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out of DENV-infectedmosquito lysate byUb3881protein, conﬁrming an
interaction between the two proteins (Fig. 6D). We also used DENV E
protein to pull out E from the infected eluate as a control (Fig. 6D, far
right panel). Finally, we performed immunoﬂuorescence analysis on
Ub3881-transfected and DENV-infected Aag2 cells using antibodies
against mosquito Ub3881 and DENV E protein. We found that Ub3881
colocalized with the envelope protein in the infected cells (Fig. 6E). To-
gether, these results indicate that Ub3881 binds DENVE andmarks it for
destruction and/or degradation.
4. Discussion
The identiﬁcation and investigation of host factors regulated during
DENV infection of themosquitomay identify new targets and pathways
important for insect immunity as well as the viral life cycle within the
transmission vector. Here, we investigated the role of the mosquito
ubiquitin protein Ub3881 that was found to be highly down-regulated
during DENV infection of Ae. aegypti [16]. Ubiquitin proteins and the
proteasome system have been known to be required for many stages
in a number of viral lifecycles, and have been shown to play both pro-and antiviral roles. Viruses employ several strategies that require host
ubiquitin to evade immune system surveillance, undergo replication,
for budding, and viralmaturation [29,31,32,34]. For example, human cy-
tomegalovirus inhibits MHC antigen presentation through the disloca-
tion of MHC class I from the endoplasmic reticulum. The now
cytoplasmic MHC-1 becomes polyubiquitinated and is promptly re-
moved for proteasome degradation [36]. This process known as
ubiquitin-dependent ER-associated degradation (ERAD) is typically
used to clean up and remove misfolded proteins from the ER [53], and
has also been shown to play a role during WNV infection [27]. During
Hepatitis C virus (HCV) infection, a ubiquitin ligase may mediate the
ubiquitination anddegradationof the core protein [54],which is notable
in light of our ﬁndings that the mosquito Ub3881 can bind and mark
DENV envelope protein for degradation. In addition, several enveloped
RNA viruses cannot complete budding without exploiting host cellular
ubiquitination mechanisms for the virion membrane [55].
Previous research has shown that signiﬁcant alterations in host pro-
tein expression and levels of components of the ubiquitin-proteasome
system have been associated with DENV infection in vivo and in vitro
[23,24,36,56,57]. Data demonstrated that pharmacological inhibition
of the ubiquitin-proteasome system at different stages of the process
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DENV and WNV titers [35,55,56]. Although the mechanisms are un-
known, the ubiquitin-proteasome also appears to be required for ﬂavi-
virus RNA translation and/or replication during infection [55] and it
was recently demonstrated that there is an important role for the ubiq-
uitin proteasome pathway in the regulation of DENV production in the
mosquito vector [37]. Consistent with this, we observed that blocking
proteasome activity with the proteasome inhibitor MG132 reduced
DENV infection in Aag2 mosquito cells without overexpression of
Ub3881. Interestingly, this blockage failed to reduce the antiviral effect
of Ub3881 in cells overexpressing the ubiquitin protein. This was per-
haps due to the need for the proteasome during DENV infection and
not because Ub3881 acts independently of the proteasome system. Pre-
vious work has demonstrated that inhibiting the proteasome system
can increase autophagy in mammalian cells [58]. Ubiquitin is also
known to play a role in selective cellular autophagy pathways [59].
For instance, the ubiquitin protein ligase Parkin has been reported to
target substrates for both autophagic and proteosomal degradation,
and this degradation is dependent on linkage through K48 [60]. If the
mosquito Ub3881 does have antiviral roles that do not involve the pro-
teasome system, a role in autophagy would be an interesting avenue to
investigate.
A recent study looking at host gene expression during DENV infec-
tion in patients and in cell lines found that several genes involved in
the ubiquitin-proteasome pathway were upregulated, both in vivo
and in vitro, and that inhibition of the ubiquitin-proteasome pathway
critically hinders dengue viral replication in mammalian cells [56]. The
proteasome inhibitors MG-132 and ALLN signiﬁcantly reduced DENV
replication in the human liver cell lines tested. However, it is unclear if
at this time whether the ubiquitin-proteasome system is antiviral or if
dengue virus uses components of the system for its advantage, perhaps
for replication [56]. Even though the proteasomemight be necessary for
DENV infection, the use of ubiquitylation to degrade viral proteins
through the proteasome would not be beneﬁcial to the life cycle. This
is just one illustration of howcomplex the ubiquitin-proteasome system
is.
There are seven lysine residues considered integral to the prototyp-
ical ubiquitin molecule (K6, K11, K27, K29, K33, K48 and K63), any of
which the carboxy-terminal glycine of ubiquitin can link to form
polyubiquitin chains [61]. Generally speaking, K63-linked
ubiquitination is involved in signaling and the regulation of kinase acti-
vation while ubiquitin chains linked through lysine 6, 11, 27, 29, 33 or
48 usually target a substrate protein for proteasomal degradation [62,
63]. Linear ubiquitin chains linked via the N-terminal amino group can
also play important nonproteolytic functions. We found that the mos-
quito ubiquitin Ub3881 has lysines at position 6, 27, 29 and 48 but not
K11, K33 or K63. In addition, an inserted alanine at position 19 shifts
the position of the downstream lysines by one position. As Ub3881
does not have a lysine at position 63 but does have K48, we hypothe-
sized that the protein may likely be acting to target proteins for degra-
dation through the proteasome rather than participating in cell
signaling or protein delivery to endosomal-lysosomal pathways [64].
We found that the Ub3881 was in fact acting to label the dengue virus
envelope protein for degradation. Whether any monoubiquitination of
dengue viral envelope protein can lead to relocation or protein interac-
tions within an infected cell remains to be investigated.
The Imd pathway is an innate immune response in insects that can
stimulate the production of antimicrobial peptides (AMP) and is rapidly
triggered during bacterial infection in Drosophila by a peptidoglycan in
the cell wall of Gram-negative and some Gram-positive bacteria [65,
66]. Interestingly, the Imd pathway is also protective against some
RNA viruses, though it is not entirely clear how viruses prompt the
Imd pathway and in what way Imd establishes resistance in return
[66]. In Drosophila, a polyubiquitin chain linked via K63 has been
found to recruit and activate the TAK1-TAB2 complex which then fur-
ther activates sections of the immune deﬁciency (Imd) pathway [65,66]. The mosquito Ub3881 does not have a lysine at positon 63 that
would be suggestive of an involvement in cell signaling or immune re-
sponse. In spite of this, we found that Ub3881 associated with Ae.
aegypti Imd protein, and increased amounts of Ub3881 resulted in in-
creased AMP signaling. Perhaps ubiquitination via a lysine other than
K63 may be the mechanism behind the Ub3881 and Imd interaction
and resulting AMP gene expression during DENV infection. Further in-
vestigation into which lysine residue may be involved in the various
functions of Ub3881, especially with regard to dengue virus infection,
is an anticipated future direction. Another component of the insect
Imd pathway is the inhibitor of apoptosis protein (IAP), which blocks
caspases from the initiation of cell apoptosis and can activate the innate
immune system through polyubiquitination [65].We found that that in-
creased amounts ofmosquitoUb3881 caused increased apoptosis, espe-
cially in cells infected by DENV. We also saw that the reduction of
Ub3881 during DENV infection resulted in a reduction in apoptosis.
This may suggest an intriguing role for Ub3881 in cell death during
DENV infection. It is interesting to speculate that the increased apopto-
sis could result from ubiquitination of IAP by Ub3881, though themech-
anisms behind this phenomenon are not entirely clear as of yet. If the
Ub3881 blocks mosquito Relish activity, this may also result in apopto-
sis, as Relish is the insect form of NFKB and an increase in NFKB activity
in mammalian cells may result in decreased apoptosis [67]. We plan to
investigate the relationship between Ub3881 and mosquito Relish pro-
tein in the near future.
It's very interesting that loss of function experiments did not impact
DENV infection in our assays. This suggests that Ub3881 may not be in-
hibitory to DENV early in infection or that the repressive effects DENV
has on Ub3881 expression could be sufﬁcient to negate the antiviral ef-
fect. As lowering Ub3881 levels before infection didn't have any beneﬁt
for DENV infection levels, one reason could be that there is no involve-
ment of the protein during early steps such as attachment and entry,
but rather that Ub3881 plays a role during replication, assembly or bud-
ding. OnceDENVproteins aremade, they likely act quickly and efﬁcient-
ly to reduce expression of Ub3881 to levels that are optimal for the later
steps in infection. The reduction of almost 100-food at one timeout dur-
ing virus infection as well as the devastating effects on infection due to
Ub3881 overexpression both indicate that this mosquito protein is ex-
tremely harmful to the DENV life cycle. The lack of beneﬁt from addi-
tional knock down could also indicate that the virus may have evolved
its mechanisms of host manipulation rather perfectly. The action of
DENV on Ub3881 expression might be enough to prevent any antiviral
effects. The loss of Ub3881 function did reduce the level of apoptosis
during DENV infection, which again points to a role for Ub3881 in apo-
ptosis of the mosquito cells during infection.
This investigation revealed that Ub3881 plays an important role dur-
ing DENV infection in the mosquito, targeting DENV E for destruction
and reducing the production of quality infectious virions. The reduction
in quality infectious virions is likely directly linked to the low availabil-
ity of envelope protein during Ub3881 overexpression, as newly pro-
duced virus requires a speciﬁc amount of DENV E. The Ub3881 protein
may also function as part of the innate immune response against
ﬂaviviruses. The targeting of DENV E for degradation and increased
AMP expression are bothways inwhich the viral life cyclewould beneﬁt
from the down-regulation of Ub3881 during infection. The data pre-
sented here adds to our knowledge of dengue virus pathogenesis in
the mosquito transmission vector. Although a traditional vaccine for
DENVmay soon be licensed for use bymanynations, and the Sanoﬁ Pas-
teur vaccine is currently licensed for use in Mexico, Brazil and the
Philippines [68,69], additional strategies involving the elimination of in-
fection in the transmission vector could serve as strong complement
vaccine approaches. Understanding the effects of dengue infection on
the mosquito, responses both common and unique to individual
ﬂaviviruses, will aid in developing broadly applicable methods to treat
and prevent infection of the mosquito vector in hopes of stopping
virus spread before human transmission. In future studies, we aim to
1908 A. Troupin et al. / Biochimica et Biophysica Acta 1860 (2016) 1898–1909further examine the ubiquitination of the dengue viral envelope protein
as well as the putative binding of Ub3881 to mosquito IAP during cellu-
lar apoptosis. We also hope to test Ub3881 peptides as inhibitors of
DENV infection in mosquitoes.
Supplementary data to this article can be found online at http://dx.
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